These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 17914416)

  • 1. Vitamin D as a novel nontraditional risk factor for mortality in hemodialysis patients: the need for randomized trials.
    Al-Aly Z
    Kidney Int; 2007 Oct; 72(8):909-11. PubMed ID: 17914416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D levels and early mortality among incident hemodialysis patients.
    Wolf M; Shah A; Gutierrez O; Ankers E; Monroy M; Tamez H; Steele D; Chang Y; Camargo CA; Tonelli M; Thadhani R
    Kidney Int; 2007 Oct; 72(8):1004-13. PubMed ID: 17687259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vitamin D, cardiovascular disease and mortality in patients with kidney disease].
    Hansen D; Brandi L; Rasmussen K
    Ugeskr Laeger; 2009 Dec; 171(50):3684-9. PubMed ID: 20003863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D supplementation in CKD.
    Martin KJ; González EA
    Clin Nephrol; 2011 Apr; 75(4):286-93. PubMed ID: 21426882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vitamin D deficiency in kidney failure. Risk factor for cardiovascular disease].
    Ohman K; Larsson T; Spaak J
    Lakartidningen; 2010 Nov 17-23; 107(46):2884-7. PubMed ID: 21197784
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of secondary hyperparathyroidism in CKD patients with cinacalcet and/or vitamin D derivatives.
    Drüeke TB; Ritz E
    Clin J Am Soc Nephrol; 2009 Jan; 4(1):234-41. PubMed ID: 19056615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic analysis of cinacalcet in combination with low-dose vitamin D versus flexible-dose vitamin D in treating secondary hyperparathyroidism in hemodialysis patients.
    Shireman TI; Almehmi A; Wetmore JB; Lu J; Pregenzer M; Quarles LD
    Am J Kidney Dis; 2010 Dec; 56(6):1108-16. PubMed ID: 20951487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond minerals and parathyroid hormone: role of active vitamin D in end-stage renal disease.
    Wolf M; Thadhani R
    Semin Dial; 2005; 18(4):302-6. PubMed ID: 16076353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use (or misuse) of vitamin D treatment in CKD and dialysis patients: A recent meta-analysis on vitamin D compounds in chronic kidney disease [1] and an editorial comment [2] accompanying this meta-analysis have already been published. We believe that these papers deserve some comments in the interest of the NDT readership.
    Olgaard K; Lewin E
    Nephrol Dial Transplant; 2008 Jun; 23(6):1786-9; discussion 1789-3. PubMed ID: 18400819
    [No Abstract]   [Full Text] [Related]  

  • 10. Vitamin D treatment in chronic kidney disease.
    Andress DL
    Semin Dial; 2005; 18(4):315-21. PubMed ID: 16076355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. When is Vitamin D contraindicated in dialysis patients?
    Evenepoel P
    Semin Dial; 2009; 22(3):242-4. PubMed ID: 19572999
    [No Abstract]   [Full Text] [Related]  

  • 12. Challenges in the therapy of secondary hyperparathyroidism.
    Wood C; González EA; Martin KJ
    Ther Apher Dial; 2005 Feb; 9(1):4-8. PubMed ID: 15828898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. When is Vitamin D contraindicated in dialysis patients?
    Khosla N; Sprague SM
    Semin Dial; 2009; 22(3):249-51. PubMed ID: 19573002
    [No Abstract]   [Full Text] [Related]  

  • 14. When is Vitamin D Contraindicated in Dialysis Patients?
    Goodman WG
    Semin Dial; 2009; 22(3):245-7. PubMed ID: 19573000
    [No Abstract]   [Full Text] [Related]  

  • 15. When is Vitamin D contraindicated in dialysis patients?
    Martin KJ
    Semin Dial; 2009; 22(3):247-9. PubMed ID: 19573001
    [No Abstract]   [Full Text] [Related]  

  • 16. [Vitamin D and survival of hemodialysis patients].
    Shoji T; Nishizawa Y
    Clin Calcium; 2004 Sep; 14(9):64-8. PubMed ID: 15577113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the effect of oral activated vitamin D on overall survival in hemodialysis patients: a landmark analysis.
    Chao JY; Chien HC; Kuo TH; Chang YT; Li CY; Wang MC; Kao Yang YH
    BMC Nephrol; 2018 Nov; 19(1):309. PubMed ID: 30400889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines for disorders of mineral metabolism and secondary hyperparathyroidism should not yet be modified.
    Ix JH; Quarles LD; Chertow GM
    Nat Clin Pract Nephrol; 2006 Jun; 2(6):337-9. PubMed ID: 16932455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dual vitamin D pathways: considerations for adequate supplementation.
    Cronin SC
    Nephrol Nurs J; 2010; 37(1):19-26, 36; quiz 27-8. PubMed ID: 20333900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paricalcitol, a new agent for the management of secondary hyperparathyroidism in patients undergoing chronic renal dialysis.
    Goldenberg MM
    Clin Ther; 1999 Mar; 21(3):432-41. PubMed ID: 10321413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.